drugset

drugset / Trial / NCT06208241

Use of Allocetra-OTS in End Stage Knee Osteoarthritis - Assessment of Safety

NCT06208241 ↗

Phase 0 Active not recruiting 18 enrolled Amir Oron Enlivex Therapeutics Ltd. · collab

NaSingle-groupOpen-labelTreatment

Summary

This is a pilot study to assess safety and possible efficacy of Allocetra-OTS in end-stage knee osteoarthritis.

Timeline

Start: 2023-07-12
Primary completion: 2026-09-25
Completion: 2026-12-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Allocetra-OTS	Cell therapy	—	Other

Indications